Javier Gordon Ogembo, PhD, City of Hope
Javier Gordon Ogembo, PhD
Dr. Ogembo's research is focused on several aspects of host pathogen interactions, with specific focus on the mechanisms by which oncogenic viruses [Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV), and human papillomavirus (HPV)] bypass cellular barriers and host immune responses, a critical step required for the development of effective vaccines.
Products
References
- Mutsvunguma LZ, Rodriguez E, Escalante GM, Muniraju M, Williams JC, Warden C, Qin H, Wang J, Wu X, Barasa A, Mulama DH, Mwangi W, Ogembo JG. Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes. Virology. 2019 Jul 30;536:1-15. doi: 10.1016/j.virol.2019.07.026. [Epub ahead of print] PubMed PMID: 31377598.
